Table 1.
Clinicopathologic characteristics of patients with metastatic STS
| Characteristic | Patients with metastatic STS (n = 142) | |
|---|---|---|
| Age, yrs | 47.5† (range: 5-71) | |
| Gender (%) | ||
| Male | 60 | 42.3% |
| Female | 82 | 57.7% |
| Primary tumor size (cm) | 5.5† (range: 0.5-20) | |
| Primary tumor depth (%) | ||
| Superficial | 44 | 31% |
| Deep | 98 | 69% |
| Pathological subtypes (%) | ||
| So-called fibrohistiocytic tumors | 22 | 15.5% |
| Undifferentiated sarcomas | 96 | 67.6% |
| Smooth muscle tumors | 22 | 15.5% |
| Fibroblastic/Myofibroblastic tumors | 2 | 1.4% |
| Pathological grade (%) | ||
| 1 | 9 | 6.3% |
| 2 | 13 | 9.2% |
| 3 | 120 | 84.5% |
| Follow-up (months) | ||
| Median | 49.38 | |
| Range | 2.97-476.17 | |
| Mean | 71.05 | |
| Local Treatment (%) | ||
| With | 79 | 55.6% |
| Without | 63 | 44.4% |
†
Median values are listed.